SEC Filing | CONMED

View:

SEC FORM 3 SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Lockwood Kimberly

(Last)

(First)

(Middle)

C/O CONMED CORPORATION

11311 CONCEPT BOULEVARD

(Street)

LARGO

33773

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
06/01/2026

3. Issuer Name and Ticker or Trading Symbol
CONMED Corp [ CNMD ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
	Officer (give title below)	Other (specify below)
Interim Corp Controller & PFO

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	1,868	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Options To Purchase Common Stock	⁽¹⁾	03/01/2028	Common Stock	1,400	59.96	D
Options To Purchase Common Stock	⁽²⁾	03/01/2029	Common Stock	3,200	78.76	D
Options To Purchase Common Stock	⁽²⁾	03/02/2030	Common Stock	3,500	97.69	D
Options To Purchase Common Stock	⁽²⁾	03/01/2031	Common Stock	3,500	122.55	D
Options To Purchase Common Stock	⁽²⁾	03/01/2032	Common Stock	2,750	144.55	D
Options To Purchase Common Stock	⁽²⁾	03/01/2033	Common Stock	2,500	96.16	D
Options To Purchase Common Stock	⁽²⁾	03/01/2034	Common Stock	2,500	79.95	D
Options To Purchase Common Stock	⁽²⁾	03/03/2035	Common Stock	4,500	58.33	D
RSUs (Restricted Stock Units)	⁽³⁾	03/02/2036	Common Stock	2,839	0	D
RSUs (Restricted Stock Units)	⁽³⁾	05/11/2036	Common Stock	2,838	0	D

Explanation of Responses:

1. The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.

2. The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period.

3. Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting over a three-year period with the first 33% of the RSUs vesting one year after the grant date, 33% second year and 34% third year.

	/s/ Thomas Fistek for Kimberly Lockwood by Power of Attorney	06/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.


CONMED CORPORATION
LIMITED POWER OF ATTORNEY FOR SECTION 16 AND RULE 144 FILINGS AND
LOCK-UP AGREEMENTS

Know all by these presents, that the undersigned hereby constitutes and
appoints each of the following attorneys of CONMED Corporation (the ?Company?):
Hollie Foust, EVP, General Counsel and Corporate Secretary; Thomas Fistek,
Chief Counsel, Assistant Corporate Secretary; Megan Zielonko, Director,
Counsel; Amber Straub, Director, Counsel; Lawrence Jordan III, Director,
Counsel; Julie Hall, Senior Manager, Corporate Programs; Celeste Templeton,
Manager Compensation; and Kira Muren, Senior Paralegal, as the undersigned?s
true and lawful attorney-in-fact to: 1. execute for and on behalf of the
undersigned, in the undersigned?s capacity as an officer or director or both of
the Company, Forms 3, 4 and 5 (and any amendments thereto) in accordance with
Section 16(a) of the Securities Exchange Act of 1934, as amended and the rules
and regulations promulgated thereunder (the ?Exchange Act?), and any Form 144
under the Securities Act of 1933, as amended, as well as any Lock-Up
Agreements; 2. do and perform any and all acts for and on behalf of the
undersigned which may be necessary or desirable to complete and execute any
such Form 3, 4, 5, Form 144 Notice or Lock-Up Agreements, complete and execute
any amendments thereto, and timely file such form, with all amendments,
supplements and exhibits thereto, with the Securities and Exchange Commission
and any securities exchange or similar authority; 3. seek or obtain, as the
undersigned?s representative and on the undersigned?s behalf, information on
transactions in the Company?s securities from any third party, including but
not limited to brokers, employee benefit plan administrators and trustees, and
the undersigned hereby authorizes any such person to release any such
information to each of the undersigned?s attorneys-in-fact appointed by this
Limited Power of Attorney and approves and ratifies any such release of
information; and 4. take any other action in connection with the foregoing
which, in the opinion of such attorney-in-fact, may be of benefit to, in the
best interest of, or legally required by or for, the undersigned, it being
understood that the documents executed by such attorney-in-fact on behalf of
the undersigned pursuant to this Limited Power of Attorney shall be in such
form and shall contain such information and disclosure as such attorney-in-fact
may approve in such attorney-in-fact?s discretion. The undersigned hereby
grants to each such attorney-in-fact, acting individually, full power and
authority to do and perform any and every act and thing whatsoever required,
necessary or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might
or could do if personally present, with full power of substitution or
revocation, hereby ratifying and confirming all that such attorney-in-fact, or
such attorney-in-fact?s substitute or substitutes, shall lawfully do or cause
to be done by virtue of this Limited Power of Attorney and the rights and
powers herein granted. The undersigned acknowledges that the foregoing
attorneys-in-fact, in serving in such capacity at the request and on the behalf
of the undersigned, are not assuming, nor is the Company assuming, any of the
undersigned?s responsibilities to comply with, or any liability for the failure
to comply with, any provision of Section 16 of the Exchange Act. This Limited
Power of Attorney shall remain in full force and effect until the undersigned
is no longer required to file Forms 3, 4, 5 and 144 and Lock-Up Agreements with
respect to the undersigned?s holdings of and transactions in securities issued
by the Company, unless earlier revoked by the undersigned in a signed writing
delivered to each of the foregoing attorneys-in-fact. IN WITNESS WHEREOF, the
undersigned has executed this Limited Power of Attorney as of this 14th day of
May, 2026. 	Signed and acknowledged: acknowledged: 	Kimberly Lockwood 	Printed
Name ACKNOWLEDGEMENT STATE OF New York York COUNTY OF Onondaga 	On May 14,
2026, before me, the undersigned, personally appeared Kimberly Lockwood
personally known to me or proved to me on the basis of satisfactory evidence to
be the individual whose name is subscribed to the within instrument and
acknowledged to me that he/she executed the same in his/her capacity, and that
by his/her signature on the instrument, the individual, or the person upon
behalf of which the individual acted, executed the instrument. 							Michael
J. Hines Notary Public: State of New York No. 01HI6269800 Commission Expires
October 9, 2028